FIELD: medicine.
SUBSTANCE: invention refers to medicine, namely cardiology, and may be used for myocardium protection against ischemic and reperfusion injures. That is ensured by the target drug delivery to the ischemic-reperfused myocardium. Aminated silica nanoparticles of the diameter of 10 nm wherein a spacer is grafter are used as a drug carrier. A drug substance is immobilised on a functional group of the spacer by one of the following methods: covalent binding, coordination ion interaction, immobilisation by adsorption.
EFFECT: technique provides the selective accumulation of the drug substance within ischemia-reperfusion after the systemic introduction of the specified complex with the minimum effect of the preparation on intact organs and tissues and good biodegradability of the carrier; surface functionalisation of said nanoparticles also provides a binding ability of the drug substances of different chemical compositions in various proportions.
2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR REDUCING THE SIZE OF ISCHEMIC-REPERFUSION MYOCARDIAL INJURY WITH THE USE OF QUINACRINE | 2019 |
|
RU2716596C1 |
| APPLICATION OF KAURAN COMPOUNDS FOR MEDICINES PRODUCTION | 2004 |
|
RU2345761C2 |
| METHOD FOR PREVENTING AND TREATING MYOCARDIAL ISCHEMIA | 2002 |
|
RU2241463C2 |
| METHOD OF CARDIOPROTECTION OF ISCHEMIC AND REPERFUSION INJURIES IN ACUTE MYOCARDIAL INFARCTION | 2019 |
|
RU2712448C1 |
| MEANS INCREASING HEART RESISTANCE TO REPERFUSION DAMAGE | 2016 |
|
RU2642826C1 |
| METHOD FOR MYOCARDIAL PROTECTION ACCOMPANYING CARDIOPULMONARY BYPASS SURGERY FOR AORTIC VALVE REPLACEMENT | 2013 |
|
RU2538044C1 |
| AGENT IMPROVING CARDIAC RESISTANCE TO ISCHEMIC AND FOLLOWING REPERFUSION INJURIES | 2012 |
|
RU2488404C1 |
| METHOD OF CARDIOPROTECTION AND NEUROPROTECTION USING INTRAVENOUS INTRODUCTION OF HALOGENIC OF FLYING ANESTHETIC | 2003 |
|
RU2350323C2 |
| CRYSTALLOID CARDIOPLEGIC SOLUTION | 2009 |
|
RU2423135C2 |
| METHOD OF MYOCARDIUM PRECONDITIONING IN OPERATIONS UNDER CONDITIONS OF ARTIFICIAL BLOOD SUPPLY | 2012 |
|
RU2504336C1 |
Authors
Dates
2012-07-20—Published
2010-04-26—Filed